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Abstract: Neuronal activity and brain glucose metabolism are tightly coupled, where triggered
neurotransmission leads to a higher demand for glucose. To better understand the regulation
of neuronal activity and its relation to high-speed metabolism, development of analytical tools
that can temporally resolve the transients of vesicular neurotransmitter release and fluctuations
of metabolites such as glucose in the local vicinity of the activated neurons is needed. Here we
present an amperometric biosensor design for rapid co-detection of glucose and the neurotransmitter
dopamine. The sensor is based on the immobilization of an ultra-thin layer of glucose oxidase on
to a gold-nanoparticle-covered carbon fiber microelectrode. Our electrode, by altering the potential
applied at the sensor surface, allows for the high-speed recording of both glucose and dopamine.
We demonstrate that, even though glucose is electrochemically detected indirectly through the
enzymatic product and the electroactive dopamine is sensed directly, when exposing the sensor
surface to a mixture of the two analytes, fluctuations in glucose and dopamine concentrations can
be visualized with similar speed and at a millisecond time scale. Hence, by minimizing the enzyme
coating thickness at the sensor surface, dual detection of glucose and dopamine can be realized
at the same sensor surface and at time scales necessary for monitoring fast metabolic alterations
during neurotransmission.
Keywords: biosensor; glucose; glucose oxidase; amperometry; co-detection; temporal resolution;
gold nanoparticles; microelectrode
1. Introduction
Enzymes are highly specific biocatalysts, converting a substrate to a product, making them
excellent for incorporation in sensors aimed at selective detection of analytes that are otherwise
difficult to detect. The first enzymatic biosensor was developed in the 1960s by Clark and Lyon for
the detection of glucose with the use of the enzyme glucose oxidase (GOx) as part of the detection
scheme [1]. Since then, there have been a tremendous number of biosensors developed for applications
within the food industry, pharmacology, neurochemistry, environmental analysis, and chemistry [2–12].
The field of biosensors has been extensively expanded and a vast array of methods for detection has
been explored [13–21]. Electrochemical detection has several advantages, such as fast sample rates,
the possibility to miniaturize the sensor by the use of microelectrodes, and high biocompatibility
of the electrode material where, e.g., carbon and gold have been successfully used for in vivo
applications [22–24]. In addition to its use in biosensor design, electrochemical detection is also
frequently employed in the study of electroactive substances, where the analyte undergoes a redox
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reaction directly at the electrode surface when a redox potential is applied. The neurotransmitter
dopamine is extensively explored by electrochemistry due to its ability to easily oxidize at a positively
polarized electrode [25,26]. Dopamine is related to the reward system of the brain, and it has a central
role in Parkinson’s disease [27,28] as well as in addiction [29]. Glucose is the primary source of
energy in the mammalian brain as its metabolism generates ATP, the fuel for cellular maintenance
and neurotransmission. It has been shown that an increase in local neuronal activity is associated
with a higher glucose concentration in the activated brain area and that glucose-excited neurons sense
fluctuations in local glucose levels [30,31]. Therefore, the ability to co-detect rapid local fluctuations of
dopamine and glucose has the potential to reveal new insights in how neuronal activity is connected
to and regulated by the energy metabolism in the brain [32].
The construction of enzyme-based electrochemical biosensors relies on the immobilization
of enzymes at an electrode surface where the enzymatic activity product can be detected [33,34].
Enzymes adsorbing to a flat surface have a tendency to flatten out, which causes an alteration of
their protein tertiary structure and often thereby a reduction in enzymatic activity. In order to
prevent enzyme denaturation upon adsorption to an electrode surface, several methods for enzyme
immobilization have been developed, e.g., enzyme attachment using cross-linkers, enzyme entrapment
in polymers, and the incorporation of nanomaterials at the sensor surface as support for enzymes to
bind [35–41]. Several studies have shown that immobilizing enzymes on a high curvature surface
is beneficial for retaining enzymatic activity by minimizing changes in the tertiary structure of
the enzyme [42–45]. Modifying the electrode surface with nanomaterials such as nanotubes and
nanoparticles (NPs) introduces a high curvature support for enzyme immobilization. Additionally,
the introduction of nanostructures will also increase the electrode surface area, thereby allowing for a
higher enzyme loading that increases the sensitivity of the sensor. Gold nanomaterials, such as gold
nanoparticles (AuNPs), have been widely used due to their high biocompatibility and increased ability
to oxidize/reduce enzymatic electroactive products, e.g., hydrogen peroxide (H2O2) [46–49].
Earlier reported glucose biosensors have not focused on applications that demand high temporal
resolution. Our aim is to develop novel miniaturized electrochemical biosensors that can be used
for analyzing real-time rapid fluctuations of non-electroactive molecules at single secretory cells and
locally by groups of cells in brain tissue. We have previously shown that a two-sequential enzyme
system, acetylcholine esterase (AChE) and choline oxidase (ChO), immobilized as a monolayer on
to an AuNP-coated carbon fiber microelectrode (CFME) can be used to detect the vesicular release
of the non-electroactive neurotransmitter acetylcholine with a millisecond temporal resolution [50].
Here, we immobilize a single enzyme system (GOx) to the surface of AuNPs covering a CFME and we
investigate the temporal resolution for glucose detection and compare it with that of the electroactive
neurotransmitter dopamine. Glucose, a non-electroactive molecule, must undergo an enzymatic
catalytic reaction by the immobilized GOx at the electrode surface in order to generate an electroactive
product that can be detected by the electrode. Each glucose molecule is enzymatically converted to
gluconic acid and H2O2, which is then reduced at the AuNP surface of the electrode held at a potential
of−0.5 V (vs. Ag/AgCl), where one H2O2 molecule generates two electrons according to the following
chemical reactions:
glucose+ O2 → gluconic acid +H2O2
H2O2 + 2H+ + 2e− → 2 H2O
In the sensor schemes used here for the high temporal dual detection of glucose and dopamine,
dopamine is oxidized at +0.5 V (vs. Ag/AgCl), a potential sufficient for diffusion limited dopamine
oxidation, and a potential where H2O2 not is detectable (Figure S1). In order to compare the kinetics
for the detection of glucose and dopamine, the two analytes must be selectively detected at the same
sensor. Here we monitor the kinetics and selective detection of glucose undergoing a catalytic reaction
by the immobilized GOx, resulting in the production of H2O2, which diffuses to the electrode surface
for electrochemical detection, and compare it to the speed for the detection of dopamine, which,
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following diffusion through the thin coating of immobilized enzyme, is directly detected when it
is in contact with the electrode surface. The results demonstrate the uniqueness of this sensor, as it
allows for the dual detection of a non-electroactive analyte and an electroactive one with the same
time resolution.
2. Results and Discussion
2.1. Preparation of the Biosensor
AuNPs were electrodeposited to the electrode surface by placement in a 0.5 mM HAuCl4 solution
and subsequent reduction of Au3+ to Au0 through application of a large overpotential (−0.6 V
vs. Ag/AgCl) for 24 s, a method originally developed by Finot et al. [51]. The electrodeposition
parameters have previously been optimized by our lab for a CFME 33 µm in diameter and provide
a coating of AuNPs approximately 20 nm in diameter with a 30% electrode surface coverage [50].
Monolayer enzyme coverage at the surface of nanoparticles has been demonstrated to be beneficial in
several aspects, e.g., a greater accessibility of the enzyme active site, a reduction of steric hindrance
between enzymes, and a faster diffusion of the enzymatic product to the electrode surface [42–44].
Glucose oxidase is an enzyme unwilling to form multiple layers when it is immobilized upon a
surface [52]. We have previously developed a method for quantifying the number of GOx enzymes
immobilized onto the surface of AuNPs coating a glassy carbon electrode, resulting in close to a
monolayer coverage at an AuNP surface [53]. Based on these previous results, we estimate that the
conditions used here for GOx immobilization (2 mg mL−1 and an incubation time of 2 h at room
temperature) results in approximately monolayer coverage of GOx.
2.2. Biosensor Characterization
The modification of the carbon surface with AuNPs fills two functions in this sensor design.
It provides a high curvature surface for enzyme immobilization and provides an electrode surface
with an enhanced ability to detect the enzymatic product H2O2. The enhanced detection ability is
important as H2O2 can only be reduced at the Au surface of the electrode—not at the carbon—and at
the potential applied in these experiments. As a consequence, since the total deposited Au surface
varies between electrodes, all current responses should be normalized to the total AuNP surface area
of each electrode in order to compare the response magnitude between electrodes. The AuNP–CFME
response to H2O2 shows linearity over a large concentration range (10 µM–10 mM) where the response
in the lower concentration range (10 µM–1 mM) is shown in Figure 1b. The sensitivity to H2O2 at the
AuNP–CFME was determined to be 8.4 ± 0.5 pA mM−1 µm−2 (R-square 0.992) in the linear range of
H2O2 concentrations tested (Figure S2). The enzymatic sensor was exposed to glucose concentrations
between 10 µM and 10 mM (Figure S3) to generate a Michaelis–Menten curve revealing a KM for
the biosensor of 0.07 ± 0.03 mM. Typically, enzymes in solution have KM values ranging between
10−1 M (low affinity) and 10−7 M (high affinity) [54]. At lower concentrations of glucose, the sensor
demonstrates a linear response between 10 µM and 100 µM, while the current reached a plateau at
1 mM glucose (Figure 1a). The sensitivity of glucose within the linear range was determined to be
1.9 ± 0.04 pA mM−1 µm−2 (R-square 0.999), which is approximately one quarter the sensitivity of
the response towards H2O2 by the AuNP–CFME, indicating a highly retained enzymatic activity of
the GOx enzyme when immobilized to the sensor surface in this concentration range. The limit of
detection for this biosensor was determined to 10 µM (3σ).





Figure  1.  (a)  A  reproducible  calibration  curve  for  glucose  using  the  glucose  oxidase  and  gold 
nanoparticle modified carbon fiber microelectrode (GOx–AuNP–CFME) (n = 7–10) when recording 
the  cathodic  current  at  −0.5 V  (vs.  an Ag/AgCl  reference  electrode)  and  normalized  the  current 
response by the total AuNP surface area at each electrode. Inset: the linear detection range of glucose 
from 10  to 100 μM.  (b) The  linear response  towards H2O2 by AuNP–CFME  (n = 3–6) at  the  lower 
concentration range  tested and recording the cathodic current at −0.5 V  (vs. an Ag/AgCl reference 
electrode). All errors are shown as standard error of the mean. 
Since  GOx  is  an  extensively  used  enzyme  in  biosensor  fabrication  with  many  different 
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applications  for monitoring,  e.g.,  alterations  in  glucose metabolism  in  relation  to  local  neuronal 
activity. To evaluate possible common interferences for the sensor in brain tissue, several biologically 
relevant  substances were  tested;  the electroactive neurotransmitters dopamine and  serotonin,  the 
non‐electroactive  neurotransmitters  glutamate  and  acetylcholine,  and  two  other  commonly 
interfering molecules, ascorbic acid and lactate. Except for lactate which is present at concentrations 







Figure 1. (a) A reproducible calibration cur r glucose using the gluc se oxidase and gold
nanoparticle modified carbon fiber microelectrode ( x–AuNP–CFME) (n = 7–10) when recording
the cathodic current at −0.5 V (vs. an Ag/AgCl reference electrode) and normalized the current
response by the total AuNP surface area at each electrode. Inset: the linear detection range of glucose
from 10 to 100 µM. (b) The linear response towards H2O2 by AuNP–CFME (n = 3–6) at the lower
concentration range tested and recording the cathodic current at −0.5 V (vs. an Ag/AgCl reference
electrode). All errors are shown as standard error of the mean.
Since GOx is an extensively used enzyme in bio ensor fabrication with ma y different approaches
for biosensor design, reported values for KM, sensitivity, linear range, and limit of detection for
GOx-based sensors are very heterogeneous, as reviewed by Zaidi and Shin [55], with KM values
ranging between 15 µM and 2 mM, while the sensitivity varies between 10 and 5000 µA mM−1 cm−2
and the limit of detection between 0.07 µM and 4.8 mM. Hence, the values obtained for our sensor fits
well in the range of what has been previously determined for nanostructured glucose sensors.
The s e ificity f the bi sensor for glucose is of importance for possib e future in vivo app ications
for monitoring, e.g., alterations in glucose metabolism in relation to local neuronal activity. To evaluate
possible common interferences for the sensor in brain tissue, several biologically relevant substances
were tested; the electroactive neurotransmitters dopamine and serotonin, the non-electroactive
neurotransmitters gluta ate and acetylcholine, and two other commonly interfering molecules,
ascorbic acid and lactate. Except fo lactate whic is pres nt at co centrations of appr ximately
1 mM, these molecules generally ccur in low conce trations in the brain tiss e environme t, typically
in the µM range [56–59], while the average resting concentration of glucose in the human brain during
normoglycemia is around 1 mM [60]. As seen in Figure 2, at 1 mM, none of the tested possible
interferences gave a response greater than 25% of the glucose signal, indicating that interfering species
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Figure 2. The resulting cathodic current recorded at −0.5 V and illustrating selectivity by the glucose
oxidase and gold nanoparticle modified carbon fiber microelectrode (GOx–AuNP–CFME) (n = 3–6)
after exposure to different possible interfering analytes in the extracellular brain tissue environment
with concentrations of 1 mM and in the presence of 1 mM glucose. Due to the possibility of analyte
detection also by the carbon at the electrode surface, the signal is not normalized to total Au surface
area. All errors are shown as standard error of the mean.
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To investigate and compare the response time for the sensor to fast local alterations in glucose
and dopamine concentrations, the kinetics of the sensor was tested by exposing the sensor surface to
controlled rapid fluctuations of the two analytes in solution. As schematically displayed in Figure 3,
by placing the tip of a glass micropipette filled with 25 mM glucose and 20 µM dopamine solution
at approximately 30 µm distance from the sensor surface, 500 ms microinjection puffs were applied
toward the electrode surface using a microinjector. Due to the higher sensor sensitivity for dopamine
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detected, through a reduction or oxidation reaction, respectively. 
When the electrode was held at −0.5 V, a sharp rise in reductive current was observed as the puff 
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Figure 3. A schematic of the experimental set-up for comparing the kinetic response for detection
of glucose (red stars) and dopamine (blue stars) using the glucose oxidase and gold nanoparticle
modified carbon fiber microelectrode (GOx–AuNP–CFME). Here a micropipette filled with a solution
mixture containing dopamine (20 µM) and glucose (25 mM) is placed approximately 30 µm from the
surface of a GOx–AuNP–CFME. Using a microinjector pump, 500 ms puffs of the solution mixture is
injected against the sensor surface placed in buffer solution creating a controlled rapid fluctuation of
the two analytes towards the electrode. By a lyi g a ote tial of +0.5 V and −0.5 V to the sensor
surface (vs. an Ag/ Cl refer nce el ctrode) th dopamine and glucose are ampero etrically detected,
through a reduction o oxidation reaction, respectively.
When the lectrode l at −0.5 V, a sharp rise in reductive current was observed as the
puf of nalyte solution reached th sensor surface, f llowed by a current decline to baseline as the
pressure on the micropipette was switche . The response to dopamine was tested by
puffing the dopamine and glucose contai i t ards the same electrode, while instead
applying a potential of +0.5 V to the electr rf . The electrode response to dopamine was used
for evaluation of the ability of the sensor to co-detect glucose and dopamine, as well as to compare
the kinetic response for the two analytes. The results sho that, in the initial rise of the current peak,
the enzymatically catalyzed reaction of glucose to H2O2, followed by the reduction of H2O2 at the
electrode, is as fast as the direct oxidation of the electroactive dopamine, with rise times (25–75%) of
the peaks of 300 ms for dopamine and 260 ms for glucose. However, the current transient returns to
the baseline faster for glucose than for dopamine. A possible explanation for this observation could
be the higher sensor detection limit for glucose as compared to dopamine, since the concentration of
analyte will quickly decrease as the pressure from the microinjector is switched off, and glucose will
more rapidly reach a concentration that is not detected by the electrode.
In summary, the results from these experiments demonstrate that, by altering the potential
applied to the sensor surface according to the respective redox potential for glucose-derived H2O2
and dopamine, rapid fluctuations of these analytes can be monitored. Even though the sensitivity
for detection of glucose versus dopamine at this sensor scheme is significantly reduced, by limiting
the coating to an ultra-thin enzyme layer during fabrication, the temporal resolution of glucose
concentration fluctuation recordings in solution is comparable to the speed of that for dopamine.
Hence, this sensor design provides a tool for correlating dopamine activity with metabolic glucose
levels at a time scale relevant for neuronal communication. As development of many enzyme-coated
electrochemical biosensors are functionalized with nanomaterials, this methodology can also be applied
for construction of biosensors that aim for dual detection of other fast fluctuating non-electroactive
and electroactive analytes that are involved in neuronal communication.
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were  performed  using  a  two‐electrode  system with  a  computer‐controlled  1000C  Series Multi‐






Figure 4. (a) The temporal respon e for detection f puffing a solution co i g 20 µM dopamine
(blue) and 25 mM glucose (red) against the biosensor ce when applying a potential of +0.5 V
and −0.5 V vs. an Ag/Ag l reference electrode, respectively. (b) Normalized detection response of
the dopamine- and glucose-containing solution. The black band indicates the timing for the 500 ms
injection pulse applied to the glass microinjection pipette.
3. Materials and Methods
3.1. Chemical Reagents
Glucose oxidase (type VII) fro Aspergillus niger, phosphate-buffered saline tablets (10 mM,
pH 7.2), sulfuric acid, copper sulfate, tetrachloroaurate, serotonin chloride, dopamine chloride, glucose,
lactic acid, monosodium glutamate, acetylcholine chloride, ascorbic acid, ferrocene methanol, tungsten
wire, and hydrogen peroxide were purchased from Sigma-Aldrich (St. Louis, MO, USA). All reagents
used where of reagent grade and used as received. Deionized water (resistivity ≥ 18 MΩ cm) was
used in all experiments.
3.2. Electrochemical Set-Up
Electrochemical measurements, cyclic voltammetry, chronoamperometry, and amperometry were
performed using a two-electrode system with a computer-controlled 1000C Series Multi-Potentiostat
(CH Instruments, Austin, TX, USA) or an Axopatch potentiostat 200B (Axon Instruments, Foster City,
CA, USA). For all experiments, a saturated Ag/AgCl was used as a reference electrode and all
potentials are reported against this reference electrode unless otherwise stated.
3.3. Preparation of a 33 µm CFME
Carbon fiber microelectrodes were prepared by aspirating single 33-µm diameter carbon fibers
(Cytec Engineered Materials, Tempe, AZ, USA) into borosilicate glass capillaries (1.2 mm O.D., 0.69 mm
I.D., Sutter Inst um nt Co., Novato, CA, USA). The filled apillaries wer then pulled t a aper
using a comm cial micropipette pull r (P-1000; Sutter Instrument Co., Novato, CA, U A) and epoxy
(Epoxy Technology, Billerica, MA, USA) was used to seal the glass-carbon fiber junction of the electrode.
The electrode tips were cut using a scalpel and polished at a 45◦ angle on a diamond dust-embedded
micropipette beveling wheel (Narishige, Inc., London, UK). The electrodes were backfilled with silver
paint or KCl (3 M) and a metal wire (tungsten and silver, respectively) was inserted and used as the
connection to the potentiostat. All electrodes were tested in 1 mM ferrocene methanol by performing
cyclic voltammetry between −0.2 and +0.6 V at 0.1 V s−1 in order to make sure the electrodes where
well-functioning by evaluating their voltammograms prior to each experiment.
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3.4. Functionalization with AuNP
Electrodes were functionalized with AuNP by an electrochemical deposition similar to Finot et al. [51]
with minor alterations. The CFME and an Ag/AgCl reference electrode were immersed in a 0.5 mM
solution of HAuCl4 in 0.5 M H2SO4. A potential of +1.2 V was applied for 10 s followed by a potential
of −0.6 V for 24 s. The AuNP surface area was then measured electrochemically by performing a linear
sweep from +1.4 V (potential held for 5 s) to +0.5 V at a rate of 0.1 V s−1 in 0.5 M H2SO4. Here a Cu/CuSO4
reference electrode was used to avoid chloride contamination. The resulting peak at approximately +0.8 V
was integrated by the inbuilt software in the 1000C Series Multi-Potentiostat (CH Instruments, Austin,
TX, USA) and the obtained charge was divided with a factor of 4.89 pC µm−2 as used by Finot et al. [51].
The electrodes used for further experiments had a total gold surface area of approximately 2000 µm2.
3.5. Immobilization of Enzymes
The tip of each electrode was immersed in a solution containing 2 mg mL−1. Glucose oxidase in
phosphate-buffered saline, (10 mM, pH 7.2) for 2 h at room temperature. After immersion, the tip of
each electrode was washed with deionized water and stored in a solution of phosphate-buffered saline
(PBS) (10 mM, pH 7.2) at 4 ◦C when not used immediately for experiments.
3.6. Characterization of the Glucose Sensor
The detection of glucose was tested using chronoamperometry in PBS. Briefly, a constant potential
where no reaction occurs (at 0 V) was held for a certain time (10 s) and then immediately changed to
−0.5 V where the reduction of the enzymatic product hydrogen peroxide takes place and held constant
until the resulting reduction current had reached a steady state (30 s). A glucose calibration curve was
performed from 10 µM to 10 mM using freshly prepared solutions from a 1 M glucose stock solution
by adding aliquots of 1, 10, and 100 mM to the bulk PBS solution followed by convection induced
by a pipette. The response of the following interferences, acetylcholine, lactate, dopamine, serotonin,
ascorbic acid, and glutamate were tested in a 1 mM concentration in the presence of 1 mM glucose with
the same chronoamperometry method as described above. The AuNP-modified CFME response to the
enzymatic product hydrogen peroxide was performed using the same method and concentrations as
for the glucose calibration. Statistical analysis and enzyme kinetic parameters where analyzed using
GraphPad Prism 7 (La Jolla, CA, USA).
For the kinetic characterization, a micropipette (o.d. 1 mm, i.d. 0.78 mm, with filament; Harvard
Apparatus, Holliston, MA, USA) was pulled on a commercial filament puller (P-1000; Sutter Instrument
Co., Novato, CA, USA) and back-filled with a solution containing 20 µM dopamine and 25 mM glucose
in PBS. The pipette was placed together with a glucose sensor in a dish containing PBS on an Olympus
IX-71 microscope (Olympus, Melville, NY, USA). Hydraulic micromanipulators (MHW-3, Narishige,
Tokyo, Japan) were used to position the pipette approximately 30 µm away from the electrode surface.
A potential was applied at the electrode vs. a silver/silver chloride reference electrode (World Precision
Instruments, Inc., Sarasota, FL, USA) also placed in the dish. A commercial patch-clamp instrument
(Axopatch 200B; Axon Instruments, Foster City, CA, USA) was used to control the potential at the
working electrode, +0.5 V for the detection of dopamine, while a negative potential of −0.5 V was
applied to detect the enzymatic product hydrogen peroxide. Pressure was applied to the back of
the pipette (Picospritzer II; General Valve Instruments, Fairfield, NJ, USA) to create a 500 ms puff of
solution towards the electrode, resulting in a peak in either reductive or oxidative current depending
on the applied potential. The current, digitized at 5 kHz, was displayed in real time (AxoScope 8.1;
Axon Instruments, Union City, CA, USA) and stored digitally. The peaks were analyzed in Igor Pro
6 (Version 6.2.2.0; WaveMetrics, Lake Oswego, OR, USA) using an Igor Procedure File designed for
analysis of quantal release by the group of David Sulzer [61].
Supplementary Materials: The following are available online at www.mdpi.com/2073-4344/8/1/34/s1, Figure S1:
Cyclic voltammetry of a CFME–AuNP in PBS buffer (black) 5 mM H2O2 (red) and 10 mM H2O2. The voltammogram
Catalysts 2018, 8, 34 8 of 10
shows that H2O2 is reduced at potentials below −0.25 V and that no oxidation reaction occurs involving H2O2 when
potential +0.5 V is applied. Figure S2: The AuNP–CFME response to H2O2 shows linearity over a large concentration
range (10 µM–10 mM) and display a sensitivity of 8.4 ± 0.5 pA mM−1 µm−2. Figure S3: The GOx–AuNP–CFME
response to glucose for the whole concentration range tested (10 µM–10 mM).
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